65 results on '"Behr, Jürgen"'
Search Results
2. Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET
3. Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry
4. Tumor seeding following CT- guided transthoracic needle biopsy in lung cancer. A case report
5. Idiopathic pulmonary fibrosis and other progressive pulmonary fibroses
6. Early mortality in German patients with lung cancer: risk factors associated with 30-and 60-day mortality
7. Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies
8. Praxisrelevante Entwicklungen in der Lungenheilkunde
9. Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
10. Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission
11. Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
12. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
13. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity
14. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’
15. Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study
16. Interstitielle Lungenerkrankungen
17. Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study
18. Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review
19. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis
20. Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?
21. Die palliative Versorgung von COPD-Patienten
22. Metatranscriptomic analysis of modified atmosphere packaged poultry meat enables prediction of Brochothrix thermosphacta and Carnobacterium divergens in situ metabolism
23. Targeted metabolomics of pellicle and saliva in children with different caries activity
24. Screening for Bronchoscopic Lung Volume Reduction: Reasons for Not Receiving Interventional Treatment
25. Proteasome activator PA200 regulates myofibroblast differentiation
26. Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung disease
27. MALDI-TOF MS fingerprinting for identification and differentiation of species within the Fusarium fujikuroi species complex
28. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
29. Correction to: Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU
30. Große Fortschritte bei Atemwegserkrankungen
31. Comparative Genomics of Lactobacillus brevis Reveals a Significant Plasmidome Overlap of Brewery and Insect Isolates
32. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis
33. Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation
34. Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials
35. Correction to: Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU
36. Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU
37. Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
38. Rating of the industrial application potential of yeast strains by molecular characterization
39. Idiopathic Pulmonary Fibrosis Among Young Patients: Challenges in Diagnosis and Management
40. FK506-binding protein 10 (FKBP10) regulates lung fibroblast migration via collagen VI synthesis
41. Interstitielle Lungenerkrankungen: Was muss der Hausarzt wissen?
42. Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial
43. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
44. Boosting the growth of the probiotic strain Lactobacillus paracasei ssp. paracasei F19
45. Dissection of exopolysaccharide biosynthesis in Kozakia baliensis
46. Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease
47. Phenotypical and molecular characterization of yeast content in the starter of “Tchoukoutou,” a Beninese African sorghum beer
48. Guidelines or guidance for better idiopathic pulmonary fibrosis management?
49. Ambrisentan in pulmonary arterial hypertension: a guide to its use in the EU
50. Erratum to: Ambrisentan: a guide to its use in pulmonary arterial hypertension in the EU
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.